H19 and colorectal carcinoma: The resistance of colorectal cancer to oxaliplatin is associated with exosomal transfer of lncRNA H19 from carcinoma-associated fibroblasts into CRC cells, which results in activation of the Wnt/β-catenin pathway [186].